BioDelivery Sciences has received approval of the New Drug Application (NDA) for Bunavail (buprenorphine and naloxone) buccal film (CIII) from...
BioDelivery Sciences International, Inc. announced that it has submitted a New Drug Application (NDA) to the FDA for Bunavail (buprenorphine...
BioDelivery Sciences International, Inc.( BDSI ) has announced that its Phase IIb clinical study assessing the efficacy and safety of...